North America Bioreactors Market Drivers and Forecasts by 2027
North America Bioreactors Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, and Others); Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, and Others); Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column, Others); End User [Research and development organizations, Biopharma Manufacturers, and Contract Manufacturing Organizations (CMOs)] and Country
- Report Date : Jun 2020
- Report Code : TIPRE00011475
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 150
The North Americabioreactors marketis expected to reach US$ 2,102.75 Mn by 2027 from US$ 1,188.50 Mn in 2019; the market is estimated to grow at a CAGR of 7.5%during 2020–2027.
The increasing adoption of single-use bioreactors and rapidly growing demand for bioreactors from biopharmaceutical and biotechnology industries are among the major factors driving the growth of the market in North America. However, stringent regulatory frameworks in different countriesrestrain the North America Bioreactors market growth to a certain extent.
A bioreactor is equipment or system engineered to provide biologically active environment for the production of various medical and pharmaceutical compounds. The vessel is used to carry out a chemical process, which involves organisms or biochemically active substances derived from such organisms. This process can either be aerobic or anaerobic. The bioreactors are commonly cylindrical, ranging in size from liters to cubic meters, and are generally made of stainless steel. Bioreactors provide a controllable environment, in terms of pH, temperature, nutrient supply, and shear stress for any cells.
The pharmaceutical industry has been growing at an unprecedented pace in recent years. The strong demand for biologics and biosimilars has driven the growth of the industry. The biopharmaceuticals industry is one of the most significant contributors to the economy of many countries. The US is the largest market for biopharmaceuticals and leader in biopharmaceutical R&D. As per the Pharmaceutical Research and Manufacturers Association (PhRMA), the US firms conduct over half the world's total pharmaceutical R&D (worth US$ 75 billion) and hold the highest number of patents in new medicines. The increasing number of biologics approvals, growing pipeline of biosimilars, and mounting investments in research activities are prime factors facilitating the growth of the industry.
Advancements in the field of bioreactors have opened many opportunities for the bioreactor market players. Leading players have been coming up with innovative products since the last few years. The improvements in bioreactors aid in the faster and easier production of biopharmaceuticals at reduced production costs. For instance, Pall Corporation launched the mPath bioreactor control systemsthat provide accurate measurement and control of single-use process development-scale bioprocesses.
Presently, various biopharma companies, research institutes, and pharmaceutical and biotech companies are engaged in conducting collaborative work to address the global issue of COVID-19 outbreak. This has eventually shifted their focus from new drugdevelopment to vaccine development against this virus strain. However, the diversion of resources from liposome-based drugs development to COVID-19 therapeutics and ventilators, among others, is likely to hamper overall productivity of the drug development industries in the next few years. However, exceptthe manufacturing and sales operations in the bioreactors industry,theutilization of bioreactors, have tremendously increased. For instance, researchers in California are using the bioreactors to analyze the activities of virus, which might assist them in vaccine discovery. These factors are projected to drive the adoption of bioreactors during post-pandemic period in North America.
Mexico Bioreactors Market,Revenue and Forecast to 2027 (US$Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICABIOREACTORS MARKET SEGMENTATION
By Cell
- Mammalian Cells
- Bacterial Cells
- Yeast Cells
- Others
By Molecule
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Stem Cells
- Gene Therapy
- Others
By Technology
- Wave-Induced Motion SUB
- Stirred SUB
- Single-Use Bubble Column
- Others
By Country
- US
- Canada
- Mexico
Companies Mentioned
- Thermo Fisher Scientific Inc
- Pall Corporation
- PBS Biotech,Inc
- General Electric Company
- MERCK KGaA
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Cell, Molecule, Technology, End User and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Bioreactors Market – By Cell
1.3.2 North America Bioreactors Market – By Molecule
1.3.3 North America Bioreactors Market – By Technology
1.3.4 North America Bioreactors Market– By End User
1.3.5 North America Bioreactors Market – By Country
2. North America Bioreactors Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Bioreactors Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Bioreactors Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Bioreactors Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Adoption of Single-Use Bioreactors
5.1.2 Increasing Demand of Bioreactors by Biopharmaceutical and Biotechnology Companies
5.2 Key Market Restraints
5.2.1 Stringent Regulatory Framework
5.3 Key Market Opportunities
5.3.1 Rising Demand of Personalized Medicine
5.4 Future Trends
5.4.1 Technological Advancements in Bioreactors
5.5 Impact Analysis
6. Bioreactors Market – North America Analysis
6.1 North America Bioreactors Market Revenue Forecasts and Analysis
7. North America Bioreactors Market Analysis and Forecasts To 2027 – By Cell
7.1 Overview
7.2 North America Bioreactors market, By Cell 2019 & 2027 (%)
7.2.1 North America Bioreactors Market Revenue and Forecasts to 2027, By Cell (US$ Mn)
7.3 Mammalian Cells
7.3.1 Overview
7.3.2 North America Mammalian Cells Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Bacterial Cells
7.4.1 Overview
7.4.2 North America Bacterial Cells Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Yeast Cells
7.5.1 Overview
7.5.2 North America Yeast Cells Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Others
7.6.1 Overview
7.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America Bioreactors Market Analysis – By Molecule
8.1 Overview
8.2 North America Bioreactors Market, By Molecule 2019-2027 (%)
8.2.1 North America Bioreactors Market Revenue and Forecasts to 2027, By Molecule (US$ Mn)
8.3 Monoclonal Antibodies
8.3.1 Overview
8.3.2 North America Monoclonal Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Vaccines
8.4.1 Overview
8.4.2 North America Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Recombinant Proteins
8.5.1 Overview
8.5.2 North America Recombinant Proteins Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Stem Cells
8.6.1 Overview
8.6.2 North America Stem Cells Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Gene Therapy
8.7.1 Overview
8.7.2 North America Gene Therapy Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Bioreactors Market Analysis – By Technology
9.1 Overview
9.2 North America Bioreactors Market, By Technology 2019-2027 (%)
9.2.1 North America Bioreactors Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
9.3 Wave-Induced Motion SUB
9.3.1 Overview
9.3.2 North America Wave-Induced Motion SUB Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Stirred SUB
9.4.1 Overview
9.4.2 North America Stirred SUB Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Single-Use Bubble Column
9.5.1 Overview
9.5.2 North America Single-Use Bubble Column Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Other Technologies
9.6.1 Overview
9.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. North America Bioreactors Market Analysis – By End-User
10.1 Overview
10.2 North America Bioreactors Market, By End-User 2019-2027 (%)
10.2.1 North America Bioreactors Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
10.3 Research and Development Organizations
10.3.1 Overview
10.3.2 North America Research and Development Organizations Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Biopharma Manufacturers
10.4.1 Overview
10.4.2 North America Biopharma Manufacturers Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Contract Manufacturing Organisations (CMOs)
10.5.1 Overview
10.5.2 North America Contract Manufacturing Organisations Market Revenue and Forecasts to 2027 (US$ Mn)
11. Bioreactors Market Revenue and Forecasts To 2027 – Geographical Analysis
11.1 North America Bioreactors Market Revenue and Forecasts To 2027
11.1.1 Overview
11.1.2 North America Bioreactors Market Revenue And Forecasts to 2027 (US$ Mn)
11.1.3 North America Bioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)
11.1.4 North America Bioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)
11.1.5 North America Bioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)
11.1.6 North America Bioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)
11.1.7 North America: Bioreactors Market, by Country, 2019 & 2027 (%)
11.1.7.1 US: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)
11.1.7.1.1 US: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)
11.1.7.1.2 US Bioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)
11.1.7.1.3 US Bioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)
11.1.7.1.4 US Bioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)
11.1.7.1.5 US Bioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)
11.1.7.2 Canada: Bioreactors Market – Revenue and Forecast to 2027 (USD Million)
11.1.7.2.1 Canada: Bioreactors Market – Revenue and Forecast to 2027 (USD Million)
11.1.7.2.2 Canada Bioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)
11.1.7.2.3 Canada Bioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)
11.1.7.2.4 Canada Bioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)
11.1.7.2.5 Canada Bioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)
11.1.7.3 Mexico: Bioreactors Market – Revenue and Forecast to 2027 (USD Million)
11.1.7.3.1 Mexico Bioreactors Market Revenue and Forecasts to 2027 (USD Million)
11.1.7.3.2 Mexico Bioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)
11.1.7.3.3 Mexico Bioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)
11.1.7.3.4 Mexico Bioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)
11.1.7.3.5 Mexico Bioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)
12. Impact Of COVID-19 Pandemic on North America Bioreactors Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
13. COMPANY PROFILES
13.1 Thermo Fisher Scientific Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Pall Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 PBS Biotech, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 General Electric Company
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 MERCK KGaA
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Bioreactors Market Revenue and Forecasts To 2027, By Cell (US$ Mn)
Table 2. North America Bioreactors Market Revenue and Forecasts To 2027, By Molecule (US$ Mn)
Table 3. North America Bioreactors Market Revenue and Forecasts To 2027, By Technology (US$ Mn)
Table 4. North America Bioreactors Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 5. North America Bioreactors Market, By Cell– Revenue And Forecast To 2027
Table 6. North America Bioreactors Market Revenue And Forecasts To 2027, By Molecule (Us$ Million)
Table 7. North America Bioreactor Market Revenue And Forecasts To 2027, By Technology (US$ Million)
Table 8. North America Bioreactors Market Revenue And Forecasts To 2027, By End User (US$ Million)
Table 9. US Bioreactors Market, By Cell – Revenue And Forecast To 2027 (USD Million)
Table 10. US Bioreactors Market, By Molecule – Revenue And Forecast To 2027 (USD Million)
Table 11. US Bioreactors Market, By Technology – Revenue And Forecast To 2027 (USD Million)
Table 12. US Bioreactors Market, By End User – Revenue And Forecast To 2027 (USD Million)
Table 13. Canada Bioreactors Market, By Cell – Revenue And Forecast To 2027 (USD Million)
Table 14. Canada Bioreactors Market, By Molecule – Revenue And Forecast To 2027 (USD Million)
Table 15. Canada Bioreactors Market, By Technology – Revenue And Forecast To 2027 (USD Million)
Table 16. Canada Bioreactors Market, By End User – Revenue And Forecast To 2027 (USD Million)
Table 17. Mexico Bioreactors Market, By Cell – Revenue And Forecast To 2027 (USD Million)
Table 18. Mexico Bioreactors Market, By Molecule – Revenue And Forecast To 2027 (USD Million)
Table 19. Mexico Bioreactors Market, By Technology – Revenue And Forecast To 2027 (USD Million)
Table 20. Mexico Bioreactors Market, By End User – Revenue And Forecast To 2027 (USD Million)
Table 21. Glossary of Terms, Bioreactors Market
LIST OF FIGURES
Figure 1. Bioreactors Market Segmentation
Figure 2. North America Bioreactors Market Overview
Figure 3. Mammalian Cells Segment Held Largest Share of Cell in Bioreactors Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Bioreactors Market - Leading Country Markets (US$ Mn)
Figure 6. Bioreactors Market - North America PEST Analysis
Figure 7. Bioreactors Market Impact Analysis of Driver and Restraints
Figure 8. North America Bioreactors market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Bioreactors market, By Cell 2019 & 2027 (%)
Figure 10. North America Mammalian Cells Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Bacterial Cells Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Yeast Cells Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Others Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Bioreactors Market, by Molecule 2019 & 2027 (%)
Figure 15. North America Monoclonal Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Recombinant Proteins Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Stem Cells Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America Gene Therapy Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America Bioreactors Market, by Technology 2019 & 2027 (%)
Figure 22. North America Wave-Induced Motion SUB Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. North America Stirred SUB Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. North America Single-Use Bubble Column Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. North America Bioreactors Market, by End-User 2019 & 2027 (%)
Figure 27. North America Research and Development Organizations Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. North America Biopharma Manufacturers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. North America Contract Manufacturing Organisations Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. North America: Bioreactors Market, by Key Country - Revenue (2019) (USD Million)
Figure 31. North America Bioreactors Market Revenue And Forecasts to 2027 (US$ Million)
Figure 32. North America: Bioreactors Market, By Country, 2019 & 2027 (%)
Figure 33. US: Bioreactors Market- Revenue And Forecasts to 2027 (USD Million)
Figure 34. Canada Bioreactors Market Revenue And Forecasts To 2027 (USD Million)
Figure 35. Mexico: Bioreactors Market – Revenue And Forecast To 2027 (USD Million)
Figure 36. Impact Of Covid-19 Pandemic In North American Country Markets
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For